BMRN Competitors & Alternatives
Compare Biomarin Pharmaceutical Inc with similar stocks in the same industry
Biotechnology
BMRN
Main Stock$59.20
Tradestie Score
66
Market Cap
$10.53B
P/E Ratio
42.5
Revenue Growth
0.0%
Analyst Upside
+48.1%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$265.22
|
$12.36B | 31.3 | 61 | Compare |
|
EXEL
Exelixis Inc
|
$56.04
|
$11.09B | 18.7 | 68 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.51
|
$10.76B | - | 67 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$67.01
|
$10.74B | - | 57 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$56.75
|
$10.49B | - | 44 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$83.08
|
$10.22B | - | 67 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$531.00
|
$10.01B | - | 66 | Compare |
|
TECH
Bio-Techne Corp.
|
$71.36
|
$9.33B | 101.9 | 53 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$85.90
|
$8.88B | 262.5 | 60 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$76.11
|
$8.77B | 26.7 | 58 | Compare |
More BMRN Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry